51 related articles for article (PubMed ID: 37021679)
1. CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response.
Ruan Y; Hu J; Che Y; Liu Y; Luo Z; Cheng J; Han Q; He H; Zhou Q
Cell Death Dis; 2022 Feb; 13(2):156. PubMed ID: 35173147
[TBL] [Abstract][Full Text] [Related]
2. Aberrant CHCHD2-associated mitochondriopathy in Kii ALS/PDC astrocytes.
Leventoux N; Morimoto S; Ishikawa M; Nakamura S; Ozawa F; Kobayashi R; Watanabe H; Supakul S; Okamoto S; Zhou Z; Kobayashi H; Kato C; Hirokawa Y; Aiba I; Takahashi S; Shibata S; Takao M; Yoshida M; Endo F; Yamanaka K; Kokubo Y; Okano H
Acta Neuropathol; 2024 May; 147(1):84. PubMed ID: 38750212
[TBL] [Abstract][Full Text] [Related]
3. Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion.
Liu T; Wetzel L; Zhu Z; Kumaraguru P; Gorthi V; Yan Y; Bukhari MZ; Ermekbaeva A; Jeon H; Kee TR; Woo JA; Kang DE
Cells; 2023 Dec; 12(24):. PubMed ID: 38132101
[TBL] [Abstract][Full Text] [Related]
4. CHCHD10
Genin EC; di Borgo PP; Lorivel T; Hugues S; Farinelli M; Mauri-Crouzet A; Lespinasse F; Godin L; Paquis-Flucklinger V; Petit-Paitel A
Neurobiol Dis; 2024 Jun; 195():106498. PubMed ID: 38583639
[TBL] [Abstract][Full Text] [Related]
5. Generation of a human iPSC line from a Parkinson's disease patient with a novel CHCHD2 mutation (p.R145Q).
Chen X; Sun J; Wang T; Tang Q; Su L; Sun Y; Chen L; Seo H; Cheng T; Wang J; Song B
Stem Cell Res; 2024 Jun; 77():103419. PubMed ID: 38631182
[TBL] [Abstract][Full Text] [Related]
6. High fat diet ameliorates mitochondrial cardiomyopathy in CHCHD10 mutant mice.
Southwell N; Manzo O; Bacman S; Zhao D; Sayles NM; Dash J; Fujita K; D'Aurelio M; Di Lorenzo A; Manfredi G; Kawamata H
EMBO Mol Med; 2024 Jun; 16(6):1352-1378. PubMed ID: 38724625
[TBL] [Abstract][Full Text] [Related]
7. High fat diet ameliorates mitochondrial cardiomyopathy in CHCHD10 mutant mice.
Southwell N; Manzo O; Zhao D; Sayles NM; Dash J; Fujita K; D'Aurelio M; Di Lorenzo A; Manfredi G; Kawamata H
bioRxiv; 2023 Dec; ():. PubMed ID: 36865125
[TBL] [Abstract][Full Text] [Related]
8. Editorial: Molecular links between mitochondrial damage and human neurodegenerative disorders, volume II.
Imai Y
Front Cell Dev Biol; 2024; 12():1417802. PubMed ID: 38742140
[No Abstract] [Full Text] [Related]
9. What is the role of CHCHD2 in adrenal tumourigenesis?
Karapanagioti A; Nasiri-Ansari N; Moustogiannis A; Trigas GC; Zografos G; Aggeli C; Kyriakopoulos G; Choreftaki T; Philippou A; Kaltsas G; Kassi E; Angelousi A
Endocrine; 2023 Aug; 81(2):357-367. PubMed ID: 37221428
[TBL] [Abstract][Full Text] [Related]
10. Elevated CHCHD4 orchestrates mitochondrial oxidative phosphorylation to disturb hypoxic pulmonary hypertension.
Wang Y; Zeng Z; Zeng Z; Chu G; Shan X
J Transl Med; 2023 Jul; 21(1):464. PubMed ID: 37438854
[TBL] [Abstract][Full Text] [Related]
11. The impacts of the mitochondrial myopathy-associated G58R mutation on the dynamic structural properties of CHCHD10.
Alici H; Uversky VN; Kang DE; Woo JA; Coskuner-Weber O
J Biomol Struct Dyn; 2024 Jul; 42(11):5607-5616. PubMed ID: 37349880
[TBL] [Abstract][Full Text] [Related]
12. Modulating Golgi Stress Signaling Ameliorates Cell Morphological Phenotypes Induced by CHMP2B with Frontotemporal Dementia-Associated p.Asp148Tyr.
Fukatsu S; Okawa M; Okabe M; Cho M; Isogai M; Yokoi T; Shirai R; Oizumi H; Yamamoto M; Ohbuchi K; Miyamoto Y; Yamauchi J
Curr Issues Mol Biol; 2024 Feb; 46(2):1398-1412. PubMed ID: 38392208
[TBL] [Abstract][Full Text] [Related]
13. Lowered oxidative capacity in spinal muscular atrophy, Jokela type; comparison with mitochondrial muscle disease.
Ratia N; Palu E; Lantto H; Ylikallio E; Luukkonen R; Suomalainen A; Auranen M; Piirilä P
Front Neurol; 2023; 14():1277944. PubMed ID: 38020590
[TBL] [Abstract][Full Text] [Related]
14. CHCHD10 mutations induce tissue-specific mitochondrial DNA deletions with a distinct signature.
Shammas MK; Nie Y; Gilsrud A; Huang X; Narendra DP; Chinnery PF
Hum Mol Genet; 2023 Dec; 33(1):91-101. PubMed ID: 37815936
[TBL] [Abstract][Full Text] [Related]
15. The identification of high-performing antibodies for Coiled-coil-helix-coiled-coil-helix domain containing protein 10 (CHCHD10) for use in Western Blot, immunoprecipitation and immunofluorescence.
Ayoubi R; Alshafie W; Southern K; McPherson PS; Laflamme C;
F1000Res; 2023; 12():403. PubMed ID: 37767023
[TBL] [Abstract][Full Text] [Related]
16. Case report: Asp194Ala variant in MFN2 is associated with ALS-FTD in an Italian family.
Vinciguerra C; Di Fonzo A; Monfrini E; Ronchi D; Cuoco S; Piscosquito G; Barone P; Pellecchia MT
Front Genet; 2023; 14():1235887. PubMed ID: 37547466
[No Abstract] [Full Text] [Related]
17. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
Shammas MK; Huang TH; Narendra DP
Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
[TBL] [Abstract][Full Text] [Related]
18. ALS and Parkinson's disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons.
Harjuhaahto S; Rasila TS; Molchanova SM; Woldegebriel R; Kvist J; Konovalova S; Sainio MT; Pennonen J; Torregrosa-Muñumer R; Ibrahim H; Otonkoski T; Taira T; Ylikallio E; Tyynismaa H
Neurobiol Dis; 2020 Jul; 141():104940. PubMed ID: 32437855
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
